AMBD yields 2000000.00% · ABBV yields 3.06%● Live data
📍 AMBD pulled ahead of the other in Year 1
Combined, AMBD + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of AMBD + ABBV for your $10,000?
American Mobile Dental Corp. engages in the ownership and operation of mobile dental offices in the northeast region of the United States. These mobile dental offices provide dental and health management services for consumers in economic development areas in New York. The company provides various services, including oral examinations, X-rays, dental prophylaxes, nutrition counseling, fluoride treatments, sealant, amalgam and composite restorations, stainless steel crowns, polycarbonate anterior crowns, root canal therapy for primary and permanent teeth, and extractions and minor oral surgery. It also manages dental centers that offer treatments, such as crown and bridge, molar root canals, orthodontics, and TMJ therapy, as well as various cosmetic procedures. In addition, American Mobile Dental provides dental screenings and educational materials to individuals at inner city schools, malls, health fairs, college campuses, senior citizen centers, convalescent homes, and elementary schools. The company was founded in 2000. It was formerly known as Tradepubz.com, Inc. and changed its name to American Mobile Dental Corp. in 2004. American Mobile Dental is headquartered in Mamaroneck, New York.
Full AMBD Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.